(Q40652357)

22 September 2017

title

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives (English)

1 reference

22 September 2017

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives (English)

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

27 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

27 December 2023

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

27 December 2023

author name string

Belén Zarranz

1

1 reference

22 September 2017

Andrés Jaso

2

1 reference

22 September 2017

Ignacio Aldana

3

1 reference

22 September 2017

Antonio Monge

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

22 September 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12713824

full work available at URL

27 December 2023

https://dadun.unav.edu/bitstream/10171/35793/1/manuscript4.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12713824

https://api.elsevier.com/content/article/PII:S0968089603001196?httpAccept=text/xml

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

https://api.elsevier.com/content/article/PII:S0968089603001196?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00119-6

Bioorganic & Medicinal Chemistry

27 December 2023

published in

1 reference

22 September 2017

volume

11

1 reference

22 September 2017

issue

10

1 reference

22 September 2017

page(s)

2149-2156

1 reference

Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Baylis-Hillman reaction: convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Studies on (beta,1-->5) and (beta,1-->6) linked octyl Gal(f) disaccharides as substrates for mycobacterial galactosyltransferase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900119-6

7 January 2021

Identifiers

1 reference

22 September 2017

1 reference